<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>26774534</identifier>
<setSpec>1699-7980</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>Alcántara-Montero, A</dc:author>
<dc:author>Brenes-Bermúdez, F J</dc:author>
<dc:type>Letter</dc:type>
<dc:language>es</dc:language>
<dc:date>2016 May </dc:date>
<dc:title xml:lang="es">¿Finasterida o dutasterida para el tratamiento farmacológico de los síntomas del tracto urinario inferior en el varón debidos a hiperplasia benigna de próstata?</dc:title>
<dc:title xml:lang="en">Finasteride or dutasteride for the pharmacological treatment for male lower urinary tract symptoms due to benign prostatic hyperplasia?</dc:title>
<dc:publisher>Actas urologicas espanolas</dc:publisher>
</metadata>
</record>
</pubmed-document>
